Publications by authors named "Xingyan Ju"

Claim this Profile
T
Targeting CREB1/p300-mediated RGS1 expression in tumor-associated macrophages improves the efficacy of anti-PD-1 therapy in triple-negative breast cancer.
Xiangyu Liu, Xingyan Ju, Ronghui Yuan, Bingxue Pan, Tongtong Feng

Biochem Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions.
Xingyan Ju, Hongsheng Yu, Donghai Liang, Tao Jiang, Yuanwei Liu

Biomed Pharmacother· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis